Cargando…

SARS-CoV-2 vaccinations complicated by transverse myelitis

Detalles Bibliográficos
Autor principal:	Finsterer, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Coronavirus – Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255207/ https://www.ncbi.nlm.nih.gov/pubmed/35417279 http://dx.doi.org/10.1080/21645515.2022.2057162

Ejemplares similares

Consider Transverse Myelitis as a Complication of a SARS-CoV-2 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2022)

Side effects of SARS-CoV-2 vaccines should be assessed by unbiased professionals on-site
por: Finsterer, Josef
Publicado: (2022)

SARS-CoV-2 vaccination complicated by acute, disseminated encephalo-myelitis?
por: Finsterer, Josef
Publicado: (2021)

Longitudinally extensive transverse myelitis after covid vaccination: Response to letter
por: Maroufi, Seyed Farzad, et al.
Publicado: (2022)

COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse events
por: Fitzsimmons, William E.
Publicado: (2022)

Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection
por: Liang, Huang, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination-Induced Transverse Myelitis
por: Tahir, Nayha, et al.
Publicado: (2021)

Acute transverse myelitis following SARS-CoV-2 infection()
por: Jauregui-Larrañaga, C., et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
por: Yu, Haiyun, et al.
Publicado: (2023)

Susceptibility of rabbits to SARS-CoV-2
por: Mykytyn, Anna Z., et al.
Publicado: (2021)

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma
por: Wang, Yingdan, et al.
Publicado: (2022)

Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants
por: Fan, Shengtao, et al.
Publicado: (2022)

Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy
por: Joshi, Gaurav, et al.
Publicado: (2022)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
por: Shete, Anita M., et al.
Publicado: (2022)

B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responses
por: Lin, Ke, et al.
Publicado: (2022)

Efficacy of vaccination against the SARS-CoV-2 virus in patients with chronic kidney disease on hemodialysis
por: Sanhueza, María E., et al.
Publicado: (2023)

SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients: SARS-CoV-2 infection impairs islet function
por: Ji, Ningfei, et al.
Publicado: (2022)

Retinal artery/vein occlusion complicating SARS-CoV-2 vaccinations
por: Finsterer, Josef
Publicado: (2022)

Reponse to Letter to The Editor: Regarding: Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines
por: Oygar, Pembe Derin, et al.
Publicado: (2022)

SARS-CoV-2 reinfection and COVID-19 severity
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs
por: Stefanizzi, Pasquale, et al.
Publicado: (2021)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
por: Jia, Yilai, et al.
Publicado: (2023)

SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
por: Xia, Shuai, et al.
Publicado: (2023)

Potent immunogenicity and broad-spectrum protection potential of microneedle array patch-based COVID-19 DNA vaccine candidates encoding dimeric RBD chimera of SARS-CoV and SARS-CoV-2 variants
por: Fan, Feng, et al.
Publicado: (2023)

Neutralization of ARCoV-induced sera against SARS-CoV-2 variants
por: Li, Xiao-Feng, et al.
Publicado: (2022)

SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: A case report
por: Hasan, Dlshad Abdullah, et al.
Publicado: (2022)

Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months
por: Sahay, Rima R., et al.
Publicado: (2022)

Undetermined Fatal Complications of SARS-CoV-2 Vaccinations Require Clarification by Autopsy
por: Finsterer, Josef
Publicado: (2022)

Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
por: Huang, Qingrui, et al.
Publicado: (2022)

Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques
por: Xu, Fang, et al.
Publicado: (2022)

mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern
por: Wang, Haomeng, et al.
Publicado: (2022)

Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
por: Wang, Meiyu, et al.
Publicado: (2021)

Reactive arthritis after vaccination against SARS-CoV-2: A case series and a mini-review
por: Wojturska, Wiktoria, et al.
Publicado: (2023)

Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
por: Yan, Vincent Ka Chun, et al.
Publicado: (2022)

Steroid-responsive, transverse myelitis is a known complication of COVID-19
por: Finsterer, J.
Publicado: (2021)

Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine
por: Chen, Lin-Lei, et al.
Publicado: (2022)

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
por: Wang, Xun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_egcv7gvjefn821hrc7ntej4rcb